Everence Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$352K Sell
2,800
-690
-20% -$86.7K 0.02% 509
2025
Q1
$386K Hold
3,490
0.03% 449
2024
Q4
$476K Buy
+3,490
New +$476K 0.03% 378